Literature DB >> 12906311

Encapsulating protein into preformed liposomes by ethanol-destabilized method.

Ching-Hua Wang1, Yi-You Huang.   

Abstract

This study describes a highly efficient method for encapsulating protein drugs into liposomes without using toxic solvents such as chloroform. Large unilamellar vesicles (LUVs) were formed by the ethanol injection method. The effects of composition of phospholipid, buffer concentration, incubation time, incubation temperature, drug loading, ethanol content, and the presence of poly(ethylene) glycol (PEG) lipids on the entrapment efficiency of protein were investigated. It was shown that these preformed LUVs could be induced to entrap protein drugs in the presence of ethanol. Protein could be efficiently encapsulated into liposomes. The interaction of the liposomes with proteins leads to the formation of multilamellar liposomes ranging in size from 70 to 120 nm, only slightly bigger than the parent LUVs from which they originated. Protein drugs were stable in the liposomal solution. There is no significant activity loss during the encapsulation process. The optimal encapsulation efficiency was achieved when 30% approximately 40% ethanol was used in encapsulating protein drugs. Due to the steric hindrance, LUVs containing a PEG coating will dramatically reduce the encapsulation efficiency, even in liposomes containing very low amount of PEG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906311     DOI: 10.1081/bio-120023160

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  5 in total

1.  Enhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loading into negatively charged liposomes.

Authors:  Jing Qin; Xu Yang; Jia Mi; Jianxin Wang; Jia Hou; Teng Shen; Yongji Li; Bin Wang; Xuri Li; Weili Zhu
Journal:  Int J Nanomedicine       Date:  2014-11-12

Review 2.  Platform technologies for modern vaccine manufacturing.

Authors:  Hayley K Charlton Hume; Linda H L Lua
Journal:  Vaccine       Date:  2017-03-25       Impact factor: 3.641

3.  Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment.

Authors:  Mohammad Najlah; Ammar Said Suliman; Ibrahim Tolaymat; Sathishkumar Kurusamy; Vinodh Kannappan; Abdelbary M A Elhissi; Weiguang Wang
Journal:  Pharmaceutics       Date:  2019-11-14       Impact factor: 6.321

Review 4.  When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications.

Authors:  Kazuaki Taguchi; Yuko Okamoto; Kazuaki Matsumoto; Masaki Otagiri; Victor Tuan Giam Chuang
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-26

5.  Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells.

Authors:  Tomoya Hada; Yu Sakurai; Hideyoshi Harashima
Journal:  Pharmaceutics       Date:  2015-09-14       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.